N/A
Completed N=23
Acceptance of the CP950 Sound Processor
Hearing Loss, Sensorineural
Source: ClinicalTrials.gov NCT03613909 ↗
Enrolled (actual)
23
Serious AEs
0.0%
Results posted
Sep 2023
Primary outcomePrimary: Acceptability Ratings for the CP950 Sound Processor Compared to Subjects' Own Processors, Summarized by the Overall Hearing Performance Score. — 3.6 Units on a likert scale
Summary
Acceptance of CP950 sound processor with experienced CP810/CP910/CP920 BTE sound processor users.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability Ratings for the CP950 Sound Processor Compared to Subjects' Own Processors, Summarized by the Overall Hearing Performance Score. |
3.6 | — |
| SECONDARY Speech Reception Threshold (SNR50) for Sentence Testing in Noise With CP950 Sound Processor . |
4 | — |
| SECONDARY Percentage of Correct Words Scored With Sentences in Noise With the CP950 Sound Processor |
49.82 | — |
Eligibility Criteria
Inclusion Criteria
- Eighteen years of age or older
- At least 6 months experience with a Nucleus 24 series or later implant in at least one implanted ear
- At least 3 months experience with the CP810,CP920 or CP910 sound processor
- Native speaker in the language used to assess speech perception performance
- Willingness to participate in and to comply with all requirements of the protocol
- Able to score 30% or more at +15 SNR with CI alone
Exclusion Criteria
- Unrealistic expectations on the part of the subject, regarding the possible benefits, risks and limitations that are inherent to the procedure and prosthetic device
- Additional disabilities that would prevent participation in evaluations
- Nucleus 22 Implant
Data sourced from ClinicalTrials.gov (NCT03613909). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.